- Home
- PETS vs MGX Comparison
PETS vs MGX Comparison
Compare PETS & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETS
- MGX
- Stock Information
- Founded
- PETS 1996
- MGX 2018
- Country
- PETS United States
- MGX United States
- Employees
- PETS N/A
- MGX N/A
- Industry
- PETS Retail-Drug Stores and Proprietary Stores
- MGX
- Sector
- PETS Consumer Staples
- MGX
- Exchange
- PETS Nasdaq
- MGX NYSE
- Market Cap
- PETS 82.0M
- MGX 70.4M
- IPO Year
- PETS N/A
- MGX 2024
- Fundamental
- Price
- PETS $4.70
- MGX $1.82
- Analyst Decision
- PETS Sell
- MGX Strong Buy
- Analyst Count
- PETS 2
- MGX 7
- Target Price
- PETS $3.50
- MGX $15.50
- AVG Volume (30 Days)
- PETS 379.1K
- MGX 378.5K
- Earning Date
- PETS 11-06-2024
- MGX 11-13-2024
- Dividend Yield
- PETS N/A
- MGX N/A
- EPS Growth
- PETS N/A
- MGX N/A
- EPS
- PETS N/A
- MGX N/A
- Revenue
- PETS $259,343,000.00
- MGX $55,080,000.00
- Revenue This Year
- PETS N/A
- MGX $0.39
- Revenue Next Year
- PETS $3.36
- MGX N/A
- P/E Ratio
- PETS N/A
- MGX N/A
- Revenue Growth
- PETS N/A
- MGX 45.13
- 52 Week Low
- PETS $2.90
- MGX $1.81
- 52 Week High
- PETS $7.94
- MGX $12.74
- Technical
- Relative Strength Index (RSI)
- PETS 54.12
- MGX 36.82
- Support Level
- PETS $4.08
- MGX $1.96
- Resistance Level
- PETS $5.90
- MGX $2.30
- Average True Range (ATR)
- PETS 0.36
- MGX 0.20
- MACD
- PETS 0.03
- MGX -0.00
- Stochastic Oscillator
- PETS 37.82
- MGX 1.89
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).